Cite
HARVARD Citation
Chan, K. et al. (2017). Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection. Liver international. pp. 434-441. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan, K. et al. (2017). Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection. Liver international. pp. 434-441. [Online].